HomeCompound-BibliothekenBioactive Compound Library-I

Bioactive Compound Library-I

Kat.-Nr.L1700

Eine einzigartige Sammlung von 10524 bioaktiven Verbindungen für das Hochdurchsatz-Screening (HTS) und das High-Content-Screening (HCS).

96 well plates

Passen Sie Ihre Bibliothek an:

Zitiert von 425 Publikationen

Bioactive Compound Library-I Inhalt

Beschreibung & Vorteile

• A unique collection of 10524 bioactive compounds for high throughput screening (HTS) and high content screening (HCS)
• Bioactivity and safety of some compounds confirmed by preclinical research and clinical trials
• Some compounds have been approved by the FDA
• Includes most Selleck inhibitors, APIs, natural products, and chemotherapeutic agents
• Structurally diverse, medicinally active, and cell permeable
• Rich documentation with structure and customer reviews
• NMR and HPLC validated to ensure high purity

Produktdetails

Formulierung 9758 compounds pre-dissolved in 10mM DMSO, 518 compounds pre-dissolved in 10mM water, 226 compounds pre-dissolved in 2mM DMSO, 20 compounds pre-dissolved in 2mM water and 2 compounds pre-dissolved in 2mg/ml DMSO
Behälter 96 Deep-Well-Platte mit Aluminiumfolie versiegelt
Stabilität 12 months -20°C in DMSO
24 months -80°C in DMSO
Versand Kühlakku oder Trockeneis

Fallstudien mit Selleck Compound-Bibliotheken

Bioactive Compound Library-I Zusammensetzung

HTS-Anlagenpartner

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania